Abstract:Chemical exchange saturation transfer (CEST) imaging is a novel contrast mechanism, relying on the exchange between mobile protons in amide (-NH), amine (-NH2) and hydroxyl (-OH) groups and bulk water. Due to the targeted protons present in endogenous molecules or exogenous compounds applied externally, CEST imaging can respectively, generate endogenous or exogenous contrast. Nowadays, CEST imaging for endogenous contrast has been explored in pre-clinical and clinical studies. Amide CEST, also called amide proton transfer weighted (APT) imaging, generates CEST effect at 3.5 ppm away from the water signal and has been widely investigated. Given the sensitivity to amide proton concentration and pH level, APT imaging has shown robust performance in the assessment of ischemia, brain tumors, breast and prostate cancer as well as neurodegenerative diseases. With advanced methods proposed, pure APT and Nuclear Overhauser Effect (NOE) mediated CEST effects were separately fitted from original APT signal. Using both effects, early but promising results were obtained for glioma patients in the evaluation of tumor response to therapy and patient survival. Compared to amide CEST, amine CEST is also mobile proton concentration and pH dependent, but has a faster exchange rate between amine protons and water. The resultant CEST effect is usually introduced at 1.8-3 ppm. Glutamate and creatine, as two main metabolites with amine groups for CEST imaging, have been applied to quantitatively assess diseases in the central nervous system and muscle system, respectively. Glycosaminoglycan (Gag) as a representative metabolite with hydroxyl groups has also been measured to evaluate the cartilage of knee or intervertebral discs in CEST MRI. Due to limited frequency difference between hydroxyl protons and water, 7T for better spectral separation is preferred over 3T for GagCEST measurement. The applications of CEST MRI with exogenous contrast agents are still quite limited in clinic. While certain diamagnetic CEST agents, such as dynamic-glucose, have been tried in human for brain tumor or neck cancer assessment, most exogenous agents, i.e., paramagnetic CEST agents, are still tested in the pre-clinical stage, mainly due to potential toxicity. Engineered tissues for tissue regeneration and drug delivery have also shown a great potential in CEST imaging, as many of them, such as hydrogel and polyamide materials, contain mobile protons or can be incorporated with CEST specific chemical compounds. These engineered tissues can thus generate CEST effect in vivo, allowing a possibility to understand the fate of them in vivo longitudinally. Although the CEST MRI with engineered tissues has only been established in early stage, the obtained first evidence is crucial for further optimizing these biomaterials and finally accomplishing the translation into clinical use.

Hematoxylin as an Exogenous MR Spectroscopic Biomarker in Tumor Molecular Imaging: A Pilot Study

Multispectral Endoscopic Imaging Studies on the Tissue Components of Gastrointestinal Mucosa

Measurement of pulmonary hematocrit using oscillation of hyperpolarized 129Xe MR signals in blood

High-content stimulated Raman histology of human breast cancer

Measurement of Hemoglobin Saturation in Tumor Microvasculature in Preclinical Models Using Hyperspectral Imaging

In Vivo Use of Hyperspectral Imaging to Develop A Noncontact Endoscopic Diagnosis Support System for Malignant Colorectal Tumors

Fiducial markers for MR histological correlation in ex vivo or short-term in vivo animal experiments: a screening study

Study Of Single Voxel H-1 Mr Spectroscopy Of Bone Tumors: Differentiation Of Benign From Malignant Tumors

[18F] Hx4: Synthesis and Tumor Hypoxia Imaging with Pet/Ct in Head and Neck Cancer

Research Progress in Bioimaging and Theranostics of Thioxanthene-hemicyanine Dyes

Influences of Experimental Parameters on Chemical Exchange Saturation Transfer (CEST) Metrics of Brain Tumors Using Animal Models at 4.7T

Contrast-enhanced susceptibility weighted imaging with ultrasmall superparamagnetic iron oxide improves the detection of tumor vascularity in a hepatocellular carcinoma nude mouse model.

Hyperspectral imaging of hemoglobin saturation in tumor microvasculature and tumor hypoxia development.

Highly Selective Imaging of Intratumoral Hydrogen Sulfide by NIR-II Emissive Fluorescent Probes

Quantitative assessment of amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging with extrapolated semi-solid magnetization transfer reference (EMR) signals: Application to a rat glioma model at 4.7 tesla.

Chemical Exchange Saturation Transfer Magnetic Resonance Imaging and Its Main and Potential Applications in Pre-Clinical and Clinical Studies.

Comparison of Multi-Echo MRS and Radial TSE Sequences in Patients with HCC

Near-Infrared Fluorescent Probe with Large Stokes Shift for Imaging of Hydrogen Sulfide in Tumor-Bearing Mice.

Label-free multiphoton microscopic imaging as a novel real-time approach for discriminating colorectal lesions: a preliminary study.

Intracellular and extracellular superparamagnetic iron oxides:Signal intensity patterns on MR imaging

Potential ability of hematoporphyrin to enhance an optical coherence tomographic image of gastric cancer in vivo in mice.